Skip to main content

Advertisement

ADVERTISEMENT

News

Advertisement

News
09/20/2019
TITUSVILLE, N.J., September 20, 2019 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today important new real-world evidence confirming XARELTO® (rivaroxaban) reduced the risk of recurrent venous thromboembolism (VTE) –...
TITUSVILLE, N.J., September 20, 2019 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today important new real-world evidence confirming XARELTO® (rivaroxaban) reduced the risk of recurrent venous thromboembolism (VTE) –...
TITUSVILLE, N.J., September 20,...
09/20/2019
Vascular Disease Management
News
09/19/2019
PARIS--(BUSINESS WIRE)--LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral arter
PARIS--(BUSINESS WIRE)--LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral arter
PARIS--(BUSINESS WIRE)--LimFlow...
09/19/2019
Vascular Disease Management

Advertisement

News
08/20/2019
Bloomington, Ind. — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum-iridium marker bands. The CXI catheter is used in small-vessel anatomy or superselective anatomy for diagnostic and...
Bloomington, Ind. — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum-iridium marker bands. The CXI catheter is used in small-vessel anatomy or superselective anatomy for diagnostic and...
Bloomington, Ind. — Cook...
08/20/2019
Vascular Disease Management
News
08/19/2019
MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement. BTG develops and...
MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement. BTG develops and...
MARLBOROUGH, Mass., Aug. 19,...
08/19/2019
Vascular Disease Management

Advertisement

News
08/08/2019
Today, FDA updated its communication to healthcare providers on paclitaxel coated devices. Based on current information, FDA recommends that physicians discuss the risks and benefits of all available peripheral arterial disease (PAD)...
Today, FDA updated its communication to healthcare providers on paclitaxel coated devices. Based on current information, FDA recommends that physicians discuss the risks and benefits of all available peripheral arterial disease (PAD)...
Today, FDA updated its...
08/08/2019
Vascular Disease Management
News
08/07/2019
August 7, 2019 — The United States Food and Drug Administration (U.S.
August 7, 2019 — The United States Food and Drug Administration (U.S.
August 7, 2019 — The United...
08/07/2019
Vascular Disease Management
News
07/30/2019
San Clemente, Calif., July 30th, 2019--(BUSINESS WIRE) --Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System.
San Clemente, Calif., July 30th, 2019--(BUSINESS WIRE) --Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System.
San Clemente, Calif., July 30th,...
07/30/2019
Vascular Disease Management

Advertisement

Advertisement